The FDA has received 11,012 adverse event reports for dogs that name Deracoxib.
- 11,012 reports name Deracoxib in dogs, which is 1.1% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 15% are marked serious and 21% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 4.0% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, anorexia and depression.
- The FDA lists 3 approved animal drug applications containing Deracoxib for dogs, the earliest approved in 2002.
- None of this is a rate. The FDA data does not record how many dogs were given Deracoxib, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,704 | 15% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 2,302 | 21% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 441 | 4.0% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 452 | 4.1% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 5,546 | 50% | 21% |
Where on the body do the reported signs sit?
Not on the body: Whole body 8.1% How it was given 5.2%
- Blood and organ tests39%elevated blood urea nitrogen (bun), elevated serum alkaline phosphatase (sap), elevated creatinine, elevated alanine aminotransferase (alt) and 7 more
- Stomach and gut37%vomiting, anorexia, diarrhoea, weight loss and 4 more
- Whole body8.1%death by euthanasia, death
- Behaviour6.6%depression
- How it was given5.2%accidental exposure
- Thirst and urination4.3%polydipsia, dehydration
Each figure is a share of sign mentions among the 25 signs reported most for Deracoxib in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting3,380 31%
- Anorexia2,421 22%
- Depression1,849 17%
- Elevated blood urea nitrogen (BUN)1,672 15%
- Elevated serum alkaline phosphatase (SAP)1,610 15%
- Diarrhoea1,478 13%
- Accidental exposure1,440 13%
- Elevated creatinine1,416 13%
Reports received per year
Is it approved for dogs?
The FDA lists 3 approved animal drug applications containing Deracoxib for dogs, the earliest approved in 2002.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| Deramaxx Chewable TabletsElanco US Inc. | Chewable Tablets RX | Dog | 2002 | 141-203 |
| DoxidylCeva Sante Animale | Chewable Tablets RX | Dog | 2019 | 200-637 |
| Deracoxib Chewable TabletsFelix Pharmaceuticals Pvt. Ltd. | Chewable Tablets RX | Dog | 2021 | 200-704 |
From the FDA record for Deramaxx Chewable Tablets: Dogs needing a dose of less than 12.5 mg can only be accurately dosed through use of the 12 mg tablet, which can be broken in half to provide 6 mg. Do not attempt to accurately dose smaller dogs through the use of breaking larger tablets. For oral use in dogs only. Do not use in cats. Federal Law (U.S.) restricts this drug to use by or on the order of a licensed veterinarian.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Nitenpyram in dogs10,786
- Maropitant in dogs11,886
- Trilostane in dogs11,925
- Lotilaner in dogs12,797
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.